Profile
Deya Corzo worked as an Executive Director-Medical at Celgene Corp.
from 2012 to 2014.
She then worked as SVP-Research & Development, Head-Therapeutic Area at uniQure NV from 2014 to 2017.
From 2017 to 2018, she served as Chief Medical Officer at Sojournix, Inc. and from 2018 to 2021, she worked as Chief Medical Officer at Sigilon Therapeutics, Inc. Dr. Corzo holds a doctorate degree from Universidad Industrial de Santander.
Former positions of Deya Corzo
| Companies | Position | End |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-07-31 |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Chief Tech/Sci/R&D Officer | 2017-12-31 |
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
| CELGENE | Corporate Officer/Principal | 2013-12-31 |
Training of Deya Corzo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Universidad Industrial de Santander
Universidad Industrial de Santander Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
- Stock Market
- Insiders
- Deya Corzo
















